TABLE 2.
Exosome markers | Location | Collection and detection methods | References |
---|---|---|---|
Alix (PDCD6IP) | Cytoplasm | Ultracentrifugation | 82,83 |
CD9 | Plasma membrane | Immunohistochemistry | 84–86 |
CD24 | Plasma | Ultracentrifugation; Immunohistochemistry | 87,88 |
CD63 | Plasma membrane and cytosol | Immunohistochemistry | 86,89,90 |
CD81 | Plasma membrane | Immunohistochemistry | 84 |
CPNE3 | Plasma | Ultracentrifugation; Immunohistochemistry | 91 |
EDIL3 | Plasma | Ultracentrifugation | 87,92 |
Exo-PD-L1 | Serum | Immunohistochemistry | 93 |
Fibronectin | Plasma | Ultracentrifugation | 87,94 |
FLOT1 | Plasma membrane | Ultracentrifugation, immunoblotting | 95,96 |
HSP70 | Serum, plasma membrane | Ultracentrifugation | 97 |
TEX | Plasma | Density gradient ultracentrifugation; size exclusion chromatography (SEC); Differential centrifugation; Ultrafiltration | 98 |
TfR | Perinuclear or plasma membrane | Ultracentrifugation; Size-exclusion chromatography (SEC) | 99,100 |
TSG101 | Cytoplasm | Ultracentrifugation, immunoblotting | 101,102 |
Abbreviations: CPNE3, Copine III; EDIL3, EGF-Like Repeats and Discoidin I-Like Domains Protein 3; Exo-PD-L1, Exosomal programmed cell-death ligand 1; FLOT1, flotillin 1; PDCD6IP, Programmed cell death 6-interacting protein; TEX, Tumor-Derived Exosomes; TfR, Transferrin receptor; TSG101, Tumor susceptibility gene 101.